National Asthma Education and Prevention Program working group report on the cost effectiveness of asthma care.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 8810630)

Published in Am J Respir Crit Care Med on September 01, 1996

Authors

S Sullivan1, A Elixhauser, A S Buist, B R Luce, J Eisenberg, K B Weiss

Author Affiliations

1: NHLBI Information Center, Bethesda, MD 20824-0105, USA.

Articles by these authors

(truncated to the top 100)

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med (2001) 27.83

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA (1994) 10.46

The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med (1992) 8.53

Global burden of COPD: systematic review and meta-analysis. Eur Respir J (2006) 7.00

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care (2001) 5.61

Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax (2003) 4.81

Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89

Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med (2000) 3.43

Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest (1999) 3.28

Changing patterns of asthma hospitalization among children: 1979 to 1987. JAMA (1990) 3.17

Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest (2000) 3.12

Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J (2002) 3.06

An estimate of the prevalence of asthma and wheezing among inner-city children. Pediatrics (1994) 2.83

The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80

Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. Lancet (2001) 2.74

Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69

Smoking and alcohol abuse: a comparison of their economic consequences. N Engl J Med (1978) 2.62

A dynamic population model of disease progression in COPD. Eur Respir J (2005) 2.59

Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J (2009) 2.52

Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med (1999) 2.36

More on RotaShield and intussusception: the role of age at the time of vaccination. J Infect Dis (2005) 2.32

Self-reported physician practices for children with asthma: are national guidelines followed? Pediatrics (2000) 2.31

Specialty differences in the management of asthma. A cross-sectional assessment of allergists' patients and generalists' patients in a large HMO. Arch Intern Med (1997) 2.28

Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health (1995) 2.16

A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med (1994) 2.11

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial. Ann Intern Med (2001) 2.06

Spirometry in the Lung Health Study. 1. Methods and quality control. Am Rev Respir Dis (1991) 1.99

Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med (1999) 1.91

Racial and gender differences in use of procedures for black and white hospitalized adults. Ethn Dis (1997) 1.91

Predicted values for closing volumes using a modified single breath nitrogen test. Am Rev Respir Dis (1973) 1.89

Present and future costs of COPD in Iceland and Norway: results from the BOLD study. Eur Respir J (2009) 1.89

Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults. Thorax (2000) 1.88

Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group. Health Econ (1997) 1.86

Chronic Obstructive Pulmonary Disease Early Intervention Trial (Lung Health Study). Baseline characteristics of randomized participants. Chest (1993) 1.85

Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis (1993) 1.82

The pharmaceutical industry and health reform: lessons from Europe. Health Aff (Millwood) (1994) 1.81

Reliability and validity of the Children's Health Survey for Asthma. Pediatrics (1999) 1.79

Patient Safety Indicators: using administrative data to identify potential patient safety concerns. Health Serv Res (2001) 1.73

Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration. Chest (1994) 1.71

Preventing deaths from asthma. N Engl J Med (1994) 1.70

Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease? Int J Tuberc Lung Dis (2009) 1.60

Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology (1999) 1.59

The relation of socioeconomic factors and racial/ethnic differences in US asthma mortality. Am J Public Health (2000) 1.59

Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine. Pharmacoeconomics (1997) 1.56

Quantitative analysis of the alveolar plateau in the diagnosis of early airway obstruction. Am Rev Respir Dis (1973) 1.56

Restricted spirometry in the Burden of Lung Disease Study. Int J Tuberc Lung Dis (2012) 1.55

Inhaled antibiotics in cystic fibrosis. Lancet (1983) 1.53

Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med (1998) 1.53

Relative impact of smoking and reduced pulmonary function on peptic ulcer risk. A prospective study of Japanese men in Hawaii. Gastroenterology (1989) 1.52

Human blood-brain barrier transferrin receptor. Metabolism (1987) 1.50

Monitoring recruitment effectiveness and cost in a clinical trial. Control Clin Trials (1993) 1.49

Human blood-brain barrier insulin receptor. J Neurochem (1985) 1.47

Cost-effectiveness of clozapine for treatment-resistant schizophrenic patients. Hosp Community Psychiatry (1990) 1.46

Physician payment reform: anesthesiology as a case study. Anesthesiology (1990) 1.43

Reported difficulties in access to quality care for children with asthma in the inner city. Arch Pediatr Adolesc Med (1998) 1.42

Associations of smoking with hospital-based care and quality of life in patients with obstructive airway disease. Chest (1999) 1.42

COPD exacerbations: the importance of a standard definition. Respir Med (2004) 1.42

Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med (1994) 1.42

Recruiting hard-to-reach subjects: is it worth the effort? Control Clin Trials (1994) 1.41

Assessing the cost-effectiveness of prevention. J Community Health (1983) 1.40

Effects of smoking and smoking cessation on longitudinal decline in pulmonary function. Am J Respir Crit Care Med (1995) 1.40

20-year trends in the prevalence of asthma and chronic airflow obstruction in an HMO. Am J Respir Crit Care Med (1998) 1.40

The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol (1999) 1.39

Caesarean section delivery and the risk of allergic disorders in childhood. Clin Exp Allergy (2005) 1.36

Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics (2001) 1.32

Annual report on access to and utilization of health care for children and youth in the United States--1999. Pediatrics (2000) 1.31

A comparison of conventional spirometric tests and the test of closing volume in an emphysema screening center. Am Rev Respir Dis (1973) 1.30

Prospective study of pulmonary function and lung cancer. Am Rev Respir Dis (1991) 1.29

Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group. Chest (1997) 1.27

An analysis of the cost effectiveness of the implantable defibrillator. Circulation (1990) 1.26

The effect of smoking cessation and modification on lung function. Am Rev Respir Dis (1976) 1.26

Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). Mol Psychiatry (2002) 1.26

Treatment differences between blacks and whites with colorectal cancer. Med Care (1996) 1.22

Further investigation into the recent increase in asthma death rates: a review of 41 asthma deaths in Oregon in 1982. Ann Allergy (1988) 1.22

Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA (1993) 1.21

A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol Psychiatry (2008) 1.18

Health care CBA and CEA from 1991 to 1996: an updated bibliography. Med Care (1998) 1.17

Health care CBA/CEA: an update on the growth and composition of the literature. Med Care (1993) 1.17

Acute effects of volcanic ash from Mount Saint Helens on lung function in children. Am Rev Respir Dis (1983) 1.15

Pediatric asthma care in US emergency departments. Current practice in the context of the National Institutes of Health guidelines. Arch Pediatr Adolesc Med (1995) 1.14

The effect of smoking cessation on pulmonary function: a 30-month follow-up of two smoking cessation clinics. Am Rev Respir Dis (1979) 1.13

Managed care pharmacy, socioeconomic assessments and drug adoption decisions. Soc Sci Med (1997) 1.13

Predictability of oppositional defiant disorder and symptom dimensions in children and adolescents with ADHD combined type. Psychol Med (2010) 1.13

Public hospitals and health care reform: choices and challenges. Am J Public Health (1996) 1.12

The increasing problem of asthma in the United States. Am Rev Respir Dis (1992) 1.12

Use of an automated prescription database to identify individuals with asthma. J Clin Epidemiol (1995) 1.11

Amyloid angiopathy of Alzheimer's disease: amino acid composition and partial sequence of a 4,200-dalton peptide isolated from cortical microvessels. J Neurochem (1987) 1.09

Preventive health measures in volcanic eruptions. Am J Public Health (1986) 1.08

National Asthma Education and Prevention Program working group report on the quality of asthma care. Am J Respir Crit Care Med (1996) 1.08

[The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study]. Dtsch Med Wochenschr (2008) 1.08

Methods of pharmacoeconomic evaluation of new medical treatments in psychiatry. Psychopharmacol Bull (1995) 1.06

The costs of smoking and the cost effectiveness of smoking-cessation programs. J Public Health Policy (1990) 1.05

Experience of Black participants in the Lung Health Study smoking cessation intervention program. Nicotine Tob Res (2001) 1.04

Pediatric asthma care in the emergency department: measuring the quality of history-taking and discharge planning. J Asthma (1999) 1.04

Early detection of airways obstruction by the closing volume technique. Chest (1973) 1.02

Quality indicators using hospital discharge data: state and national applications. Jt Comm J Qual Improv (1998) 1.02

The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA). Mol Psychiatry (2002) 1.02

Health and economic outcomes modeling practices: a suggested framework. Value Health (2006) 1.02

Increased use of an expensive, elective procedure: total hip replacements in the 1980s. Med Care (1993) 1.01

Observations on emerging patterns of asthma in our society. J Allergy Clin Immunol (1999) 1.01